公开(公告)号：US20210137921A1

公开(公告)日：2021-05-13

申请号：US17157047

申请日：2021-01-25

Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

Inventor： Nitin Bhalachandra DHARMADIKARI ,  Yashoraj R. ZALA ,  Ashwini GADKARI

IPC: A61K31/505 ,  A61K9/16 ,  A61K9/48 ,  A61K9/50

Abstract: A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.

公开(公告)号：US20180200190A1

公开(公告)日：2018-07-19

申请号：US15742739

申请日：2016-07-08

Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

Inventor： Nitin B. DHARMADHIKARI ,  Yashoraj R. ZALA ,  Bramhanand HANAMANNAVAR

IPC: A61K9/20 ,  A61K31/485 ,  A61K47/32

CPC classification number: A61K9/2013 ,  A61K9/1641 ,  A61K9/2027 ,  A61K9/2095 ,  A61K31/167 ,  A61K31/192 ,  A61K31/196 ,  A61K31/485 ,  A61K47/32 ,  A61K2300/00

Abstract: An immediate-release, abuse-resistant solid dosage form comprising melt extrudates of a mixture of: hydrocodone or its pharmaceutically acceptable salt, release inhibiting agent comprising one or more reverse enteric polymer and one or more alkalizer and one or more stabilizers.